Insights

Telstra (ASX:TLS) share price withstands its LetsVaxx campaign backlash

Telstra has joined a number of other ASX 200 shares in encouraging COVID vaccinations.
The post Telstra (ASX:TLS) share price withstands its LetsVaxx campaign backlash appeared first on The Motley Fool Australia. –

Our largest telco is the latest major company getting in on the act to encourage COVID-19 vaccinations, and the Telstra Corporation Ltd (ASX: TLS) share price is holding up despite the controversy from its campaign.

The Telstra share price inched up 0.1% to $3.86 in after lunch trade. That may not be much of a move, but it’s a positive sign as the S&P/ASX 200 Index fell 0.3%.

Investors are unperturbed by the backlash from some of Telstra’s customers to its “LetsVaxx” campaign, reported News.com.au.

Telstra share price inches up as vaccination campaign draws heat

The telco is offering fully vaccinated customers bonus Telstra Plus Points and it has put “#LetsVaxx” on every customers mobile phone.

However, some customers have reacted angrily to the message. They either believe its an invasion of their privacy and/or do not believe in getting vaccinated.

“Hey Telstra stick your #letsvaxx hashtag that you’ve stuck at the top of my device fair up ya clacker,” one customer wrote, according to News.com.au.

Some are even threatening to terminate their Telstra service unless the company removed the hashtag.

Telstra standing firm

But that isn’t likely to happen. For one, it appears most people support Telstra’s move as several have applauded the company for encouraging people to get the jab.

Our political leaders believe vaccination are the only way for life to return to any kind of normality.

Telstra has also stood by its campaign. It said it respected everyone’s right to choose whether to get vaccinated and pointed out that all Telstra Plus customers will be eligible for bonuses regardless of their vaccination status.

The bonuses include free movie, food delivery discounts, and discounts on items in its rewards store.

Paying employees to get the jab

What’s more, Telstra has hired satirist Mark Humphries for a social media campaign to bust common COVID myths.

“Mark’s sharp satire successfully busted conspiracy theories around 5G and now we’re calling on him to help cut through the noise and debunk Covid-19 vaccination myths,” News.com.au reported Telstra’s chief executive Andy Penn as saying.

The company is also offering employees $200 to get the shots and more than 5,500 of them have taken up the offer.

Other ASX 200 shares backing COVID vaccinations

But Telstra isn’t the only one on the ASX 200 share benchmark to encourage vaccinations. Qantas Airways Limited (ASX: QAN) is offering to reward its customers who are fully vaccinated and requires all customer facing staff to be immunised.

Others jumping in on the act include the Transurban Group (ASX: TCL) share price, National Australia Bank Ltd. (ASX: NAB) share price and Bapcor Ltd (ASX: BAP) share price.

The post Telstra (ASX:TLS) share price withstands its LetsVaxx campaign backlash appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of August 16th 2021

More reading

Analysts name 2 ASX 200 dividend shares to buy

The Telstra (ASX:TLS) share price is now trading on a forecast 4.2% fully franked dividend yield
Brokers name 3 ASX shares to buy today

If you invested $1,000 in Telstra (ASX:TLS) shares a decade ago, here’s what it would be worth now
5 things to watch on the ASX 200 on Friday

Motley Fool contributor Brendon Lau owns shares of National Australia Bank Limited and Telstra Corporation Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Bapcor and Telstra Corporation Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!